What is the fate of a persistently infected (PI) BVD animal in case of exposure to both homologous and heterogeneous cytopoathic BVDV at the same time? Please i want an answer from the immunologic and clinical aspects.

More Ahmed Mohamed Samir Menshawy's questions See All
Similar questions and discussions